FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to industrial microbiology. The probiotic bacterial strain Lactobacillus delbrueckii MB386 deposited in DSMZ 10.12.2008 under registration No. DSM 22106 as an inhibitor of Coliform bacteria of the species Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter aerogenes, Enterobacter cloacae and Enterococcus faecalis. The pharmaceutical composition for inhibiting Coliform bacteria of the species Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter aerogenes, Enterobacter cloacae and Enterococcus faecalis containing the bacterial strain Lactobacillus delbrueckii MB386 deposited in DSMZ. An edible composition containing the bacterial strain Lactobacillus delbrueckii MB386.
EFFECT: using the bacterial strain Lactobacillus delbrueckii MB386 as an ingredient of the pharmaceutical or edible composition enables inhibiting Coliform bacteria effectively.
20 cl, 2 tbl, 2 dwg, 7 ex
